O	O	O	0	3	DNA	DNA	B-NP	NN	O	3	NMOD	O
O	O	O	4	11	triplex	triplex	I-NP	NN	O	3	NMOD	O
O	O	O	12	21	formation	formation	I-NP	NN	O	5	SUB	O
O	O	O	22	33	selectively	selectively	B-ADVP	RB	O	5	VMOD	O
O	O	O	34	42	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
T1	B-Protein	B-Protein	43	54	granulocyte	granulocyte	B-NP	NN	B-cell_type	5	OBJ	B-cell_type
T1	I-Protein	I-Protein	54	55	-	-	I-NP	HYPH	O	6	NMOD	O
T1	I-Protein	I-Protein	55	65	macrophage	macrophage	B-NP	NN	B-DNA	9	NMOD	B-DNA
T1	I-Protein	I-Protein	66	72	colony	colony	I-NP	NN	I-DNA	7	OBJ	I-DNA
T1	I-Protein	I-Protein	72	73	-	-	O	HYPH	I-DNA	9	P	I-DNA
T1	I-Protein	I-Protein	73	84	stimulating	stimulate	B-VP	VBG	I-DNA	9	NMOD	I-DNA
T1	I-Protein	I-Protein	85	91	factor	factor	B-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	O	92	96	gene	gene	I-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	O	97	107	expression	expression	I-NP	NN	O	11	OBJ	O
O	O	O	108	110	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	111	116	human	human	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	O	117	118	T	T	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	O	119	124	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	124	125	.	.	O	.	O	5	P	O

T2	B-Protein	B-Protein	127	138	Granulocyte	Granulocyte	B-NP	NN	B-protein	7	NMOD	B-protein
T2	I-Protein	I-Protein	138	139	-	-	O	HYPH	I-protein	7	NMOD	I-protein
T2	I-Protein	I-Protein	139	149	macrophage	macrophage	B-NP	NN	I-protein	7	NMOD	I-protein
T2	I-Protein	I-Protein	150	156	colony	colony	I-NP	NN	I-protein	7	NMOD	I-protein
T2	I-Protein	I-Protein	156	157	-	-	O	HYPH	I-protein	7	NMOD	I-protein
T2	I-Protein	I-Protein	157	168	stimulating	stimulate	B-VP	VBG	I-protein	7	NMOD	I-protein
T2	I-Protein	I-Protein	169	175	factor	factor	B-NP	NN	I-protein	13	SUB	I-protein
O	O	O	176	177	(	(	O	(	O	12	DEP	O
T3	B-Protein	B-Protein	177	179	GM	GM	B-NP	NN	B-protein	11	NMOD	B-protein
T3	I-Protein	I-Protein	179	180	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T3	I-Protein	I-Protein	180	183	CSF	CSF	I-NP	NN	I-protein	12	DEP	I-protein
O	O	O	183	184	)	)	O	)	O	7	NMOD	O
O	O	O	185	187	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	188	189	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	190	201	hemopoietic	hemopoietic	I-NP	JJ	B-protein	17	NMOD	B-protein
O	O	O	202	208	growth	growth	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	209	215	factor	factor	I-NP	NN	I-protein	13	PRD	I-protein
O	O	O	216	220	that	that	B-NP	WDT	O	17	NMOD	O
O	O	O	221	223	is	be	B-VP	VBZ	O	18	SBAR	O
O	O	O	224	233	expressed	express	I-VP	VBN	O	19	VC	O
O	O	O	234	236	in	in	B-PP	IN	O	20	VMOD	O
O	O	O	237	246	activated	activate	B-NP	VBN	B-cell_type	32	NMOD	B-cell_type
O	O	O	247	248	T	T	I-NP	NN	I-cell_type	24	NMOD	I-cell_type
O	O	O	249	254	cells	cell	I-NP	NNS	I-cell_type	32	NMOD	I-cell_type
O	O	O	254	255	,	,	O	,	O	32	P	O
O	O	O	256	267	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	32	NMOD	B-cell_type
O	O	O	267	268	,	,	O	,	O	32	P	O
O	O	O	269	280	macrophages	macrophage	B-NP	NNS	B-cell_type	32	NMOD	B-cell_type
O	O	O	280	281	,	,	O	,	O	32	P	O
O	O	O	282	285	and	and	O	CC	O	32	NMOD	O
O	O	O	286	297	endothelial	endothelial	B-NP	JJ	B-cell_type	32	NMOD	B-cell_type
O	O	O	298	303	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	I-cell_type
O	O	O	303	304	.	.	O	.	O	13	P	O

O	O	O	305	313	Although	Although	B-SBAR	IN	O	20	VMOD	O
T4	B-Protein	B-Protein	314	316	GM	GM	B-NP	NNP	B-protein	4	NMOD	B-protein
T4	I-Protein	I-Protein	316	317	-	-	O	HYPH	I-protein	4	NMOD	I-protein
T4	I-Protein	I-Protein	317	320	CSF	CSF	B-NP	NNP	I-protein	5	SUB	I-protein
O	O	O	321	325	does	do	B-VP	VBZ	O	1	SBAR	O
O	O	O	326	329	not	not	I-VP	RB	O	5	VMOD	O
O	O	O	330	336	appear	appear	I-VP	VB	O	5	VC	O
O	O	O	337	339	to	to	I-VP	TO	O	9	VMOD	O
O	O	O	340	342	be	be	I-VP	VB	O	7	VMOD	O
O	O	O	343	352	essential	essential	B-ADJP	JJ	O	9	PRD	O
O	O	O	353	356	for	for	B-PP	IN	O	10	AMOD	O
O	O	O	357	363	normal	normal	B-NP	JJ	O	13	NMOD	O
O	O	O	364	375	hemopoiesis	hemopoiesis	I-NP	NN	O	11	PMOD	O
O	O	O	375	376	,	,	O	,	O	20	P	O
O	O	O	377	391	overexpression	overexpression	B-NP	NN	O	20	SUB	O
O	O	O	392	394	of	of	B-PP	IN	O	15	NMOD	O
T5	B-Protein	B-Protein	395	397	GM	GM	B-NP	NNP	O	19	NMOD	O
T5	I-Protein	I-Protein	397	398	-	-	B-NP	HYPH	O	19	NMOD	O
T5	I-Protein	I-Protein	398	401	CSF	CSF	I-NP	NN	B-protein	16	PMOD	B-protein
O	O	O	402	405	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	406	410	been	be	I-VP	VBN	O	20	VC	O
O	O	O	411	421	implicated	implicate	I-VP	VBN	O	21	VC	O
O	O	O	422	424	in	in	B-PP	IN	O	22	VMOD	O
O	O	O	425	428	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	429	441	pathogenesis	pathogenesis	I-NP	NN	O	23	PMOD	O
O	O	O	442	444	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	445	449	some	some	B-NP	DT	O	28	NMOD	O
O	O	O	450	458	diseases	disease	I-NP	NNS	O	26	PMOD	O
O	O	O	459	463	such	such	B-PP	JJ	O	30	PMOD	O
O	O	O	464	466	as	as	I-PP	IN	O	28	NMOD	O
O	O	O	467	474	myeloid	myeloid	B-NP	JJ	O	32	NMOD	O
O	O	O	475	483	leukemia	leukemia	I-NP	NN	O	35	NMOD	O
O	O	O	484	487	and	and	O	CC	O	35	NMOD	O
O	O	O	488	495	chronic	chronic	B-NP	JJ	O	35	NMOD	O
O	O	O	496	508	inflammation	inflammation	I-NP	NN	O	30	PMOD	O
O	O	O	508	509	.	.	O	.	O	20	P	O

O	O	O	510	512	An	An	B-NP	DT	O	8	NMOD	O
T18,T19	B-Entity,B-Entity	B-Entity,B-Entity	513	515	NF	NF	I-NP	NN	B-protein	4	NMOD	B-protein
T18,T19	I-Entity,I-Entity	I-Entity,I-Entity	515	516	-	-	B-NP	HYPH	I-protein	4	P	I-protein
T18,T19	I-Entity,I-Entity	I-Entity,I-Entity	516	522	kappaB	kappaB	I-NP	NN	I-protein	8	NMOD	I-protein
T18	I-Entity	I-Entity	522	523	/	/	I-NP	SYM	O	8	P	O
T18	I-Entity	I-Entity	523	526	Rel	Rel	I-NP	NN	B-protein	8	NMOD	B-protein
T18	I-Entity	I-Entity	527	534	binding	binding	I-NP	NN	I-protein	8	NMOD	I-protein
T18	I-Entity	I-Entity	535	539	site	site	I-NP	NN	I-protein	20	SUB	I-protein
O	O	O	540	546	within	within	B-PP	IN	O	8	NMOD	O
O	O	O	547	550	the	the	B-NP	DT	O	14	NMOD	O
T6	B-Protein	B-Protein	551	553	GM	GM	I-NP	NNP	O	14	NMOD	O
T6	I-Protein	I-Protein	553	554	-	-	I-NP	HYPH	O	14	NMOD	O
T6	I-Protein	I-Protein	554	557	CSF	CSF	I-NP	NN	B-DNA	14	NMOD	B-DNA
T20	B-Entity	B-Entity	558	566	promoter	promoter	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	O	566	567	,	,	O	,	O	8	P	O
O	O	O	568	574	termed	term	B-VP	VBN	O	8	NMOD	O
O	O	O	575	578	the	the	B-NP	DT	O	19	NMOD	O
T21	B-Entity	B-Entity	579	585	kappaB	kappaB	I-NP	NN	B-DNA	19	NMOD	B-DNA
T21	I-Entity	I-Entity	586	593	element	element	I-NP	NN	I-DNA	16	VMOD	I-DNA
O	O	O	594	601	appears	appear	B-VP	VBZ	O	0	ROOT	O
O	O	O	602	604	to	to	I-VP	TO	O	22	VMOD	O
O	O	O	605	607	be	be	I-VP	VB	O	20	VMOD	O
O	O	O	608	617	important	important	B-ADJP	JJ	O	22	PRD	O
O	O	O	618	621	for	for	B-PP	IN	O	23	AMOD	O
O	O	O	622	633	controlling	control	B-VP	VBG	O	24	PMOD	O
O	O	O	634	644	expression	expression	B-NP	NN	O	25	OBJ	O
O	O	O	645	647	in	in	B-PP	IN	O	26	NMOD	O
T22	B-Entity	B-Entity	648	656	reporter	reporter	B-NP	NN	B-DNA	30	NMOD	B-DNA
T22	I-Entity	I-Entity	657	661	gene	gene	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	662	668	assays	assay	I-NP	NNS	O	27	PMOD	O
O	O	O	669	671	in	in	B-PP	IN	O	25	VMOD	O
O	O	O	672	680	response	response	B-NP	NN	O	31	PMOD	O
O	O	O	681	683	to	to	B-PP	TO	O	32	NMOD	O
O	O	O	684	685	a	a	B-NP	DT	O	35	NMOD	O
O	O	O	686	692	number	number	I-NP	NN	O	33	PMOD	O
O	O	O	693	695	of	of	B-PP	IN	O	35	NMOD	O
O	O	O	696	703	stimuli	stimulus	B-NP	NNS	O	36	PMOD	O
O	O	O	704	706	in	in	B-PP	IN	O	35	NMOD	O
O	O	O	707	708	T	T	B-NP	NN	B-cell_type	40	NMOD	B-cell_type
O	O	O	709	714	cells	cell	I-NP	NNS	I-cell_type	38	PMOD	I-cell_type
O	O	O	714	715	.	.	O	.	O	20	P	O

O	O	O	716	718	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	719	731	investigated	investigate	B-VP	VBD	O	0	ROOT	O
T23	B-Entity	B-Entity	732	747	oligonucleotide	oligonucleotide	B-NP	NN	O	2	OBJ	O
O	O	O	747	748	-	-	B-VP	HYPH	O	3	NMOD	O
O	O	O	748	756	directed	direct	B-NP	VBN	O	8	NMOD	O
O	O	O	757	763	triple	triple	I-NP	JJ	O	8	NMOD	O
O	O	O	764	769	helix	helix	I-NP	NN	O	8	NMOD	O
O	O	O	770	779	formation	formation	I-NP	NN	O	4	OBJ	O
O	O	O	780	786	across	across	B-PP	IN	O	8	NMOD	O
O	O	O	787	791	this	this	B-NP	DT	O	12	NMOD	O
T24	B-Entity	B-Entity	792	802	regulatory	regulatory	I-NP	JJ	B-DNA	12	NMOD	B-DNA
T24	I-Entity	I-Entity	803	811	sequence	sequence	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	O	812	814	as	as	B-PP	IN	O	2	VMOD	O
O	O	O	815	816	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	817	826	potential	potential	I-NP	JJ	O	16	NMOD	O
O	O	O	827	831	tool	tool	I-NP	NN	O	13	PMOD	O
O	O	O	832	834	to	to	B-VP	TO	O	18	VMOD	O
O	O	O	835	842	inhibit	inhibit	I-VP	VB	O	16	NMOD	O
T7	B-Protein	B-Protein	843	845	GM	GM	B-NP	NNP	O	23	NMOD	O
T7	I-Protein	I-Protein	845	846	-	-	I-NP	HYPH	O	23	NMOD	O
T7	I-Protein	I-Protein	846	849	CSF	CSF	I-NP	NN	B-DNA	23	NMOD	B-DNA
O	O	O	850	854	gene	gene	I-NP	NN	I-DNA	23	NMOD	I-DNA
O	O	O	855	868	transcription	transcription	I-NP	NN	O	18	OBJ	O
O	O	O	868	869	.	.	O	.	O	2	P	O

O	O	O	870	871	A	A	B-NP	DT	O	5	NMOD	O
T25	B-Entity	B-Entity	872	874	15	15	I-NP	CD	O	5	NMOD	O
T25	I-Entity	I-Entity	874	875	-	-	I-NP	HYPH	O	5	NMOD	O
T25	I-Entity	I-Entity	875	879	base	base	I-NP	NN	O	5	NMOD	O
T25	I-Entity	I-Entity	880	895	oligonucleotide	oligonucleotide	I-NP	NN	O	7	NMOD	O
O	O	O	895	896	,	,	O	,	O	7	P	O
T26	B-Entity	B-Entity	897	900	GM3	GM3	B-NP	NN	B-DNA	9	SUB	B-DNA
O	O	O	900	901	,	,	O	,	O	7	P	O
O	O	O	902	905	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	906	914	targeted	target	I-VP	VBN	O	9	VC	O
O	O	O	915	917	to	to	B-PP	TO	O	10	VMOD	O
O	O	O	918	919	a	a	B-NP	DT	O	16	NMOD	O
T27	B-Entity	B-Entity	920	926	purine	purine	I-NP	NN	B-DNA	16	NMOD	B-DNA
T27	I-Entity	I-Entity	926	927	-	-	B-NP	HYPH	I-DNA	16	NMOD	I-DNA
T27	I-Entity	I-Entity	927	931	rich	rich	I-NP	JJ	I-DNA	16	NMOD	I-DNA
T27	I-Entity	I-Entity	932	938	region	region	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	939	941	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	942	945	the	the	B-NP	DT	O	23	NMOD	O
T8	B-Protein	B-Protein	946	948	GM	GM	I-NP	NNP	O	23	NMOD	O
T8	I-Protein	I-Protein	948	949	-	-	I-NP	HYPH	O	23	NMOD	O
T8	I-Protein	I-Protein	949	952	CSF	CSF	I-NP	NN	B-DNA	23	NMOD	B-DNA
T28	B-Entity	B-Entity	953	961	proximal	proximal	I-NP	JJ	I-DNA	23	NMOD	I-DNA
T28	I-Entity	I-Entity	962	970	promoter	promoter	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	O	970	971	,	,	O	,	O	16	P	O
O	O	O	972	977	which	which	B-NP	WDT	O	16	NMOD	O
O	O	O	978	986	overlaps	overlap	B-VP	VBZ	O	25	SBAR	O
O	O	O	987	990	the	the	B-NP	DT	O	29	NMOD	O
T29	B-Entity	B-Entity	991	997	kappaB	kappaB	I-NP	NN	B-DNA	29	NMOD	B-DNA
T29	I-Entity	I-Entity	998	1005	element	element	I-NP	NN	I-DNA	26	OBJ	I-DNA
O	O	O	1005	1006	.	.	O	.	O	9	P	O

O	O	O	1007	1010	Gel	Gel	B-NP	NN	O	4	NMOD	O
O	O	O	1011	1019	mobility	mobility	I-NP	NN	O	4	NMOD	O
O	O	O	1020	1025	shift	shift	I-NP	NN	O	4	NMOD	O
O	O	O	1026	1032	assays	assay	I-NP	NNS	O	8	NMOD	O
O	O	O	1033	1036	and	and	O	CC	O	8	NMOD	O
T9	B-Protein	B-Protein	1037	1042	DNase	DNase	B-NP	NN	B-protein	8	NMOD	B-protein
T9	I-Protein	I-Protein	1043	1044	I	I	I-NP	CD	I-protein	6	NMOD	I-protein
O	O	O	1045	1057	footprinting	footprinting	I-NP	NN	O	9	SUB	O
O	O	O	1058	1070	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	1071	1075	that	that	B-SBAR	IN	O	9	VMOD	O
T30	B-Entity	B-Entity	1076	1079	GM3	GM3	B-NP	NN	B-DNA	12	SUB	B-DNA
O	O	O	1080	1086	formed	form	B-VP	VBD	O	10	SBAR	O
O	O	O	1087	1088	a	a	B-NP	DT	O	14	NMOD	O
T31	B-Entity	B-Entity	1089	1097	sequence	sequence	I-NP	NN	O	18	NMOD	O
T31	I-Entity	I-Entity	1097	1098	-	-	B-NP	HYPH	O	18	P	O
T31	I-Entity	I-Entity	1098	1106	specific	specific	I-NP	JJ	O	18	NMOD	O
T31	I-Entity	I-Entity	1107	1116	collinear	collinear	I-NP	JJ	O	18	NMOD	O
T31	I-Entity	I-Entity	1117	1124	triplex	triplex	I-NP	NN	O	12	OBJ	O
O	O	O	1125	1129	with	with	B-PP	IN	O	12	VMOD	O
O	O	O	1130	1133	its	its	B-NP	PRP$	O	25	NMOD	O
T32	B-Entity	B-Entity	1134	1140	double	double	I-NP	JJ	B-DNA	25	NMOD	B-DNA
T32	I-Entity	I-Entity	1140	1141	-	-	I-NP	HYPH	I-DNA	25	NMOD	I-DNA
T32	I-Entity	I-Entity	1141	1149	stranded	stranded	I-NP	JJ	I-DNA	25	NMOD	I-DNA
T32,T33	I-Entity,B-Entity	I-Entity,B-Entity	1150	1153	DNA	DNA	I-NP	NN	I-DNA	25	NMOD	I-DNA
T32	I-Entity	I-Entity	1154	1160	target	target	I-NP	NN	I-DNA	19	PMOD	I-DNA
O	O	O	1160	1161	.	.	O	.	O	9	P	O

O	O	O	1162	1169	Triplex	Triplex	B-NP	NN	O	2	NMOD	O
O	O	O	1170	1179	formation	formation	I-NP	NN	O	5	SUB	O
O	O	O	1180	1182	by	by	B-PP	IN	O	2	NMOD	O
T34	B-Entity	B-Entity	1183	1186	GM3	GM3	B-NP	NN	B-DNA	3	PMOD	B-DNA
O	O	O	1187	1194	blocked	block	B-VP	VBD	O	0	ROOT	O
O	O	O	1195	1206	recombinant	recombinant	B-NP	JJ	O	12	NMOD	O
O	O	O	1207	1210	and	and	I-NP	CC	O	12	NMOD	O
O	O	O	1211	1218	nuclear	nuclear	I-NP	JJ	B-protein	9	NMOD	B-protein
O	O	O	1219	1221	NF	NF	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	1221	1222	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	O	1222	1228	kappaB	kappaB	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1229	1237	proteins	protein	I-NP	NNS	I-protein	5	OBJ	I-protein
O	O	O	1238	1245	binding	bind	B-VP	VBG	O	12	NMOD	O
O	O	O	1246	1248	to	to	B-PP	TO	O	12	NMOD	O
O	O	O	1249	1252	the	the	B-NP	DT	O	19	NMOD	O
T10	B-Protein	B-Protein	1253	1255	GM	GM	I-NP	NNP	O	19	NMOD	O
T10	I-Protein	I-Protein	1255	1256	-	-	I-NP	HYPH	O	19	NMOD	O
T10	I-Protein	I-Protein	1256	1259	CSF	CSF	I-NP	NN	B-DNA	19	NMOD	B-DNA
T35	B-Entity	B-Entity	1260	1267	element	element	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	1267	1268	.	.	O	.	O	5	P	O

T36	B-Entity	B-Entity	1269	1272	GM3	GM3	B-NP	NN	B-DNA	3	SUB	B-DNA
O	O	O	1273	1277	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	O	1278	1284	caused	cause	B-VP	VBD	O	0	ROOT	O
O	O	O	1285	1294	selective	selective	B-NP	JJ	O	5	NMOD	O
O	O	O	1295	1305	inhibition	inhibition	I-NP	NN	O	3	OBJ	O
O	O	O	1306	1308	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1309	1312	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1313	1318	human	human	I-NP	JJ	B-protein	13	NMOD	B-protein
O	O	O	1319	1320	T	T	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1320	1321	-	-	I-NP	HYPH	I-protein	13	P	I-protein
O	O	O	1321	1325	cell	cell	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1326	1339	lymphotrophic	lymphotrophic	I-NP	JJ	I-protein	13	NMOD	I-protein
O	O	O	1340	1345	virus	virus	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	1345	1346	-	-	B-NP	HYPH	I-protein	17	P	I-protein
O	O	O	1346	1347	1	1	I-NP	CD	I-protein	17	NMOD	I-protein
T11	B-Protein	B-Protein	1348	1351	Tax	Tax	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	1352	1366	transactivator	transactivator	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	1366	1367	-	-	B-NP	HYPH	O	21	P	O
O	O	O	1367	1374	induced	induce	I-NP	VBN	O	21	NMOD	O
O	O	O	1375	1385	luciferase	luciferase	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1386	1394	activity	activity	I-NP	NN	O	6	PMOD	O
O	O	O	1395	1399	from	from	B-PP	IN	O	21	NMOD	O
O	O	O	1400	1401	a	a	B-NP	DT	O	25	NMOD	O
O	O	O	1402	1410	reporter	reporter	I-NP	NN	B-DNA	25	NMOD	B-DNA
O	O	O	1411	1420	construct	construct	I-NP	NN	I-DNA	22	PMOD	I-DNA
O	O	O	1421	1427	driven	drive	B-VP	VBN	O	25	NMOD	O
O	O	O	1428	1430	by	by	B-PP	IN	O	26	VMOD	O
O	O	O	1431	1434	the	the	B-NP	DT	O	32	NMOD	O
T12	B-Protein	B-Protein	1435	1437	GM	GM	I-NP	NNP	O	32	NMOD	O
T12	I-Protein	I-Protein	1437	1438	-	-	I-NP	HYPH	O	32	NMOD	O
T12	I-Protein	I-Protein	1438	1441	CSF	CSF	I-NP	NN	B-DNA	32	NMOD	B-DNA
T37	B-Entity	B-Entity	1442	1450	promoter	promoter	I-NP	NN	I-DNA	27	PMOD	I-DNA
O	O	O	1451	1453	in	in	B-PP	IN	O	32	NMOD	O
O	O	O	1454	1460	Jurkat	Jurkat	B-NP	NN	B-cell_line	36	NMOD	B-cell_line
O	O	O	1461	1462	T	T	I-NP	NN	I-cell_line	36	NMOD	I-cell_line
O	O	O	1463	1468	cells	cell	I-NP	NNS	I-cell_line	33	PMOD	I-cell_line
O	O	O	1468	1469	.	.	O	.	O	3	P	O

O	O	O	1470	1477	Finally	Finally	B-ADVP	RB	O	5	VMOD	O
O	O	O	1477	1478	,	,	O	,	O	5	P	O
T38	B-Entity	B-Entity	1479	1482	GM3	GM3	B-NP	NN	B-DNA	5	SUB	B-DNA
O	O	O	1483	1490	greatly	greatly	B-VP	RB	O	5	VMOD	O
O	O	O	1491	1498	reduced	reduce	I-VP	VBD	O	0	ROOT	O
O	O	O	1499	1502	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1503	1516	concentration	concentration	I-NP	NN	O	5	OBJ	O
O	O	O	1517	1519	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	1520	1530	endogenous	endogenous	B-NP	JJ	O	8	PMOD	O
T13	B-Protein	B-Protein	1531	1533	GM	GM	I-NP	NNP	O	13	NMOD	O
T13	I-Protein	I-Protein	1533	1534	-	-	I-NP	HYPH	O	13	NMOD	O
T13	I-Protein	I-Protein	1534	1537	CSF	CSF	I-NP	NN	B-RNA	13	NMOD	B-RNA
O	O	O	1538	1542	mRNA	mRNA	I-NP	NN	I-RNA	9	NMOD	I-RNA
O	O	O	1543	1550	induced	induce	B-VP	VBN	O	9	NMOD	O
O	O	O	1551	1553	by	by	B-PP	IN	O	14	VMOD	O
O	O	O	1554	1563	different	different	B-NP	JJ	O	17	NMOD	O
O	O	O	1564	1571	stimuli	stimulus	I-NP	NNS	O	15	PMOD	O
O	O	O	1572	1574	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	1575	1581	Jurkat	Jurkat	B-NP	NN	B-cell_line	21	NMOD	B-cell_line
O	O	O	1582	1583	T	T	I-NP	NN	I-cell_line	21	NMOD	I-cell_line
O	O	O	1584	1589	cells	cell	I-NP	NNS	I-cell_line	18	PMOD	I-cell_line
O	O	O	1590	1593	but	but	O	CC	O	5	VMOD	O
O	O	O	1594	1597	did	do	B-VP	VBD	O	5	VMOD	O
O	O	O	1598	1601	not	not	I-VP	RB	O	23	VMOD	O
O	O	O	1602	1608	affect	affect	I-VP	VB	O	23	VC	O
T14	B-Protein	B-Protein	1609	1620	interleukin	interleukin	B-NP	NN	B-RNA	28	NMOD	B-RNA
T14	I-Protein	I-Protein	1621	1622	3	3	I-NP	CD	I-RNA	28	NMOD	I-RNA
O	O	O	1623	1627	mRNA	mRNA	I-NP	NN	I-RNA	29	NMOD	I-RNA
O	O	O	1628	1634	levels	level	I-NP	NNS	O	25	OBJ	O
O	O	O	1635	1637	in	in	B-PP	IN	O	29	NMOD	O
O	O	O	1638	1641	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	1642	1646	same	same	I-NP	JJ	O	33	NMOD	O
O	O	O	1647	1652	cells	cell	I-NP	NNS	O	30	PMOD	O
O	O	O	1652	1653	.	.	O	.	O	5	P	O

O	O	O	1654	1656	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	1657	1665	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	O	1666	1670	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	1671	1674	the	the	B-NP	DT	O	6	NMOD	O
T39	B-Entity	B-Entity	1675	1681	kappaB	kappaB	I-NP	NN	B-DNA	6	NMOD	B-DNA
T39	I-Entity	I-Entity	1682	1689	element	element	I-NP	NN	I-DNA	13	SUB	I-DNA
O	O	O	1690	1692	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	1693	1696	the	the	B-NP	DT	O	12	NMOD	O
T15	B-Protein	B-Protein	1697	1699	GM	GM	I-NP	NNP	O	12	NMOD	O
T15	I-Protein	I-Protein	1699	1700	-	-	I-NP	HYPH	O	12	NMOD	O
T15	I-Protein	I-Protein	1700	1703	CSF	CSF	I-NP	NN	B-DNA	12	NMOD	B-DNA
T40	B-Entity	B-Entity	1704	1712	promoter	promoter	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	O	1713	1718	plays	play	B-VP	VBZ	O	3	SBAR	O
O	O	O	1719	1720	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	1721	1728	central	central	I-NP	JJ	O	16	NMOD	O
O	O	O	1729	1733	role	role	I-NP	NN	O	13	OBJ	O
O	O	O	1734	1736	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	1737	1740	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	1741	1756	transcriptional	transcriptional	I-NP	JJ	O	20	NMOD	O
O	O	O	1757	1767	activation	activation	I-NP	NN	O	17	PMOD	O
O	O	O	1768	1770	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1771	1774	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	1775	1785	endogenous	endogenous	I-NP	JJ	O	27	NMOD	O
T16	B-Protein	B-Protein	1786	1788	GM	GM	I-NP	NNP	O	27	NMOD	O
T16	I-Protein	I-Protein	1788	1789	-	-	I-NP	HYPH	O	27	NMOD	O
T16	I-Protein	I-Protein	1789	1792	CSF	CSF	I-NP	NN	B-DNA	27	NMOD	B-DNA
O	O	O	1793	1797	gene	gene	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	O	1797	1798	.	.	O	.	O	2	P	O

O	O	O	1799	1807	Colinear	Colinear	B-NP	JJ	O	3	NMOD	O
O	O	O	1808	1815	triplex	triplex	I-NP	NN	O	3	NMOD	O
O	O	O	1816	1825	formation	formation	I-NP	NN	O	4	SUB	O
O	O	O	1826	1830	acts	act	B-VP	VBZ	O	0	ROOT	O
O	O	O	1831	1833	as	as	B-PP	IN	O	4	VMOD	O
O	O	O	1834	1835	a	a	B-NP	DT	O	9	NMOD	O
O	O	O	1836	1845	selective	selective	I-NP	JJ	O	9	NMOD	O
O	O	O	1846	1861	transcriptional	transcriptional	I-NP	JJ	O	9	NMOD	O
O	O	O	1862	1871	repressor	repressor	I-NP	NN	O	5	PMOD	O
O	O	O	1872	1874	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1875	1878	the	the	B-NP	DT	O	15	NMOD	O
T17	B-Protein	B-Protein	1879	1881	GM	GM	I-NP	NNP	O	15	NMOD	O
T17	I-Protein	I-Protein	1881	1882	-	-	I-NP	HYPH	O	15	NMOD	O
T17	I-Protein	I-Protein	1882	1885	CSF	CSF	I-NP	NN	B-DNA	15	NMOD	B-DNA
O	O	O	1886	1890	gene	gene	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	O	1891	1894	and	and	O	CC	O	4	VMOD	O
O	O	O	1895	1898	may	may	B-VP	MD	O	4	VMOD	O
O	O	O	1899	1903	have	have	I-VP	VB	O	17	VC	O
O	O	O	1904	1913	potential	potential	B-NP	JJ	O	20	AMOD	O
O	O	O	1914	1925	therapeutic	therapeutic	I-NP	JJ	O	21	NMOD	O
O	O	O	1926	1937	application	application	I-NP	NN	O	18	OBJ	O
O	O	O	1938	1940	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	1941	1946	cases	case	B-NP	NNS	O	22	PMOD	O
O	O	O	1947	1949	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	1950	1961	undesirable	undesirable	B-NP	JJ	O	26	NMOD	O
O	O	O	1962	1976	overexpression	overexpression	I-NP	NN	O	24	PMOD	O
O	O	O	1977	1979	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	1980	1984	this	this	B-NP	DT	O	29	NMOD	O
O	O	O	1985	1992	protein	protein	I-NP	NN	O	27	PMOD	O
O	O	O	1992	1993	.	.	O	.	O	4	P	O
